🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is a new emerging concept that Botulinum Toxin Type A may have a pote...
Status
Unknown
Location
Banha University Hospitals
Start Date
2019-03-10
Trial ID
NCT04172558
Treatments Being Tested
The main purpose of the study is to evaluate the safety and to establish th...
Status
Completed
Location
Hospital Clínic de Bacelona
Start Date
2015-06
Trial ID
NCT02413645
For patients with Prostate Cancer advances in medical technology have enabl...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-09
Trial ID
NCT00577876
Treatments Being Tested
The objective of the study is to assess the efficacy and safety of TriMix t...
Status
Completed
Location
Novovision ophthalmologic clinic
Start Date
2023-07-01
Trial ID
NCT06478134
Treatments Being Tested
Patients with early breast cancer and accessible tumor lesions (1.00 to 10 ...
Status
Unknown
Location
UZ Brussel
Start Date
2018-11-12
Trial ID
NCT03788083
The purpose of this study is to assess the safety and tolerability of cance...
Status
Terminated
Location
032-004_GZA Sint-Augustinus
Start Date
2017-06-27
Trial ID
NCT03394937
Treatments Being Tested
RATIONALE: Vaccines made from a person's dendritic cells and antigens may m...
Status
Completed
Location
Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Erlangen
Start Date
2003-07
Trial ID
NCT00074230
Treatments Being Tested
Evidence has been arising that Botulinum toxin injections can relax smooth ...
Status
Completed
Location
Cairo University Hospitals
Start Date
2015-10
Trial ID
NCT02584686
Treatments Being Tested
iHIVARNA-01 is a novel therapeutic vaccine for the treatment of HIV-1-infec...
Status
Terminated
Location
Institute for Tropical Medicine
Start Date
2017-04-04
Trial ID
NCT02888756
Treatments Being Tested
The CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), h...
Status
Completed
Location
UZ Brussel
Start Date
2011-02
Trial ID
NCT01302496
Treatments Being Tested